4-[[4-fluoro-3-(2-morpholino-7,8-dihydro-5H-pyrido[4,3-d]pyrimidine-6-carbonyl)phenyl]methyl]-2H-phthalazin-1-one

ID: ALA5186702

PubChem CID: 168280715

Max Phase: Preclinical

Molecular Formula: C27H25FN6O3

Molecular Weight: 500.53

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CCc2nc(N3CCOCC3)ncc2C1

Standard InChI:  InChI=1S/C27H25FN6O3/c28-22-6-5-17(14-24-19-3-1-2-4-20(19)25(35)32-31-24)13-21(22)26(36)34-8-7-23-18(16-34)15-29-27(30-23)33-9-11-37-12-10-33/h1-6,13,15H,7-12,14,16H2,(H,32,35)

Standard InChI Key:  UNFNNUKCQHJNEE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 37 42  0  0  0  0  0  0  0  0999 V2000
   -5.3572    1.8548    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6426    2.2671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9307    1.8551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9307    1.0300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6407    0.6182    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -5.3572    1.0263    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2160    2.2677    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5014    1.8551    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5014    1.0299    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2160    0.6173    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2160    3.0929    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2160   -0.2077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5015   -0.6203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7866   -0.2079    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0745   -0.6199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0745   -1.4454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7848   -1.8572    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5015   -1.4491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3599   -1.8579    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3599   -0.2073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3599    0.6178    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3546   -0.6199    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0693   -0.2073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7839   -0.6199    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7839   -1.4451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0693   -1.8577    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3546   -1.4451    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4965   -0.2090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2115   -0.6215    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2133   -1.4426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5017   -1.8592    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9279   -1.8551    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.6426   -1.4426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3572   -1.8551    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3572   -2.6804    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.6426   -3.0929    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9279   -2.6804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  3  7  1  0
  8  7  1  0
  9  8  1  0
 10  9  2  0
  4 10  1  0
  7 11  2  0
 10 12  1  0
 12 13  1  0
 14 13  2  0
 15 14  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 13 18  1  0
 16 19  1  0
 15 20  1  0
 20 21  2  0
 20 22  1  0
 23 22  1  0
 24 23  1  0
 25 24  2  0
 26 25  1  0
 27 26  1  0
 22 27  1  0
 24 28  1  0
 29 28  2  0
 30 29  1  0
 31 30  2  0
 25 31  1  0
 30 32  1  0
 33 32  1  0
 34 33  1  0
 35 34  1  0
 36 35  1  0
 37 36  1  0
 32 37  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5186702

    ---

Associated Targets(Human)

HCC1937 (423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-468 (9477 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MCF7 (126967 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MX1 (889 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-BR-3 (5175 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PARP1 Tclin Poly [ADP-ribose] polymerase-1 (6206 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 500.53Molecular Weight (Monoisotopic): 500.1972AlogP: 2.48#Rotatable Bonds: 4
Polar Surface Area: 104.31Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.96CX Basic pKa: 2.57CX LogP: 2.55CX LogD: 2.55
Aromatic Rings: 4Heavy Atoms: 37QED Weighted: 0.46Np Likeness Score: -1.95

References

1. Lin S, Zhang X, Yu Z, Huang X, Xu J, Liu Y, Wu L..  (2022)  Synthesis of novel dual target inhibitors of PARP and EGFR and their antitumor activities in triple negative breast cancers.,  61  [PMID:35393219] [10.1016/j.bmc.2022.116739]

Source